Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts

Journal of Vascular Surgery

Volumn 25, Issue 3, 1997, Pages 453-463

  Fulton, G J ^a   Davies, M G ^a   Koch, W J ^a   Dalen, H ^a   Svendsen, E ^a   Hagen, P O ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; MALE; MITOGENESIS; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTO ONCOGENE; RABBIT; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; VEIN GRAFT;

EID: 0030975713     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(97)70255-6     Document Type: Article

References (31)

1. MG Davies P-O. Hagen Pathobiology of intimal hyperplasia Br J Surg 81 1994 1254 1269
2. CC. Haudenschild Morphology of intimal hyperplasia J Vasc Surg 10 1989 591
3. S el-Massry E Saad LR Sauvage Femoropopliteal bypass with externally supported knitted Dacron grafts: a follow up of 200 grafts for one to twelve years J Vasc Surg 19 1994 487 494
4. TG John PA Stonebridge J Kelman JA Murie AM Jenkins CV. Ruckley Above-knee femoro-popliteal bypass grafts and the consequences of graft failure Ann R Coll Surg Engl 75 1993 257 260
5. MG Hunick JB Wong MC Donaldson MF Meyerovitz DP. Harrington Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease Med Decis Making 14 1994 71 81
6. T Sasajima Y Kubo M Kokubo Y Izumi M. Inaba Comparison of reversed and in situ saphenous vein grafts for infragenicular bypass: experience of two surgeons Cardiovasc Surg 1 1993 38 43
7. LM Taylor JM. Porter Clinical and anatomic considerations for surgery in femoropopliteal disease and the results of surgery Circulation 83 2 Suppl 1991 I63 I69
8. YG Wilson MG Wyatt IC Currie RN Baird PM. Lamont Preferential use of vein for above-knee femoropopliteal grafts Eur J Vasc Endovasc Surg 10 1995 220 225
9. JL Mills RM Fujitani SM. Taylor The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five year prospective study J Vasc Surg 17 1993 195 204
10. HD Berkowitz AD Fox DH. Deaton Reversed vein graft stenosis: early diagnosis and management J Vasc Surg 15 1992 130 142
11. K Varty KE Allen PRF Bell NJM. London Infrainguinal vein graft stenosis Br J Surg 80 1993 825 833
12. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990's Nature (London) 362 1993 801 809
13. B Luscher RN. Eisenmann New light on Myc and Myb. Part 2 Myb Genes Dev 4 1990 2235 2241
14. B Luscher RN. Eisenmann New light on Myc and Myb. Part 1 Myc Genes Dev 4 1990 2025 2035
15. RD. Rosenberg Vascular smooth muscle cell proliferation: basic investigations and new therapeutic approaches Thromb Haemost 70 1993 10 16
16. J-J Toulme C. Helene Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression-a review Gene 72 1988 51 58
17. M Simons ER Edelman J-L DeKeyser R Langer RD Rosenberg Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Nature 359 1992 67 70
18. AE Villa LA Guzman EJ Poptic Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel injury Circ Res 76 1995 505 513
19. MG Davies L Barber H Dalen E Svendsen P-O. Hagen Control of the structural and functional consequences of vein graft intimal hyperplasia by a 21-aminosteroid (U74389G) Eur J Vasc Surg 8 1994 448 456
20. P Chomczynski N. Sacchi Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 161 1987 156 159
21. WJ Koch HA Rockman P Samama Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor Science 268 1995 1350 1353
22. BS Goodfellow EM. Mikat A stain for the simultaneous demonstration of collagen, muscle and elastic elements in mammalian tissue Lab Med 19 1988 243 244
23. DJ. Finney Quantal responses and the tolerance distribution DJ Finney Statistical methods in biological assay. 1978 Charles Griffin London 349 369
24. M Simons RD. Rosenberg Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro Circ Res 70 1992 835 843
25. TL Burgess EF Fisher SL Ross The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism Proc Natl Acad Sci U S A 92 1995 4051 4055
26. MJ Mann GH Gibbons RS Kernoff Genetic engineering of vein grafts resistant to atherosclerosis Proc Natl Acad Sci U S A 92 1995 4502 4506
27. GJ Fulton MG Davies P-O. Hagen Locally applied antisense oligonucleotide to PCNA inhibits intimal hyperplasia formation in experimental vein grafts FASEB J 10 1996 A619
28. ER. Edelman Antisense strategies for controlling the vascular response to injury J Vasc Surg 24 1996 168 169
29. PB Dobrin FN Littooy ED. Endean Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts Surgery 105 1989 393 400
30. MG Davies P-O. Hagen Pathophysiology of vein graft failure Eur J Vasc Endovasc Surg 9 1995 7 18
31. MG Davies H Dalen A-MS Austerheim TF Gulbrandsen E Svendsen P-O. Hagen Suppression of intimal hyperplasia in experimental vein grafts by oral L-arginine supplementation and single ex vivo immersion in desferrioxamine manganese J Vasc Surg 23 1996 410 420